ConductScience.org, home

Paper3027845

Itraconazole: pharmacologic studies in animals and humans.

Van Cauteren H and 3 others. Rev Infect Dis, 1987. Cited by 94 papers, by iCite.

Cite this record

ConductScience Library. Itraconazole: pharmacologic studies in animals and humans. Papers, record 3027845. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3027845

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Itraconazole: pharmacologic studies in animals and humans.
PubMed
Journal
Rev Infect Dis
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
94
iCite
Relative citation ratio, by iCite
4.6
iCite
Revised in PubMed
2019-08-28
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Van Cauteren HH
2Heykants JJ
3De Coster RR
4Cauwenbergh GG

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifungal AgentsMajor topic
KetoconazoleMajor topic
Adrenal Glands
Animals
Dogs
Female
Guinea Pigs
Humans
Itraconazole
Kinetics
Male
Mice
Rabbits
Rats
Testis

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.

PMIDTitleJournalYearIn PapersSource
41372740Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer.Nat Commun2025https://conductscience.org/library/papers/41372740PubMed
34647162
Development and Optimization of Itraconazole-Loaded Solid Lipid Nanoparticles for Topical Administration Using High Shear Homogenization Process by Design of Experiments: In Vitro, Ex Vivo and In Vivo Evaluation.
AAPS PharmSciTech2021https://conductscience.org/library/papers/34647162PubMed
31867560Investigation of the Detailed Internal Structure and Dynamics of Itraconazole by Solid-State NMR Measurements.ACS Omega2019https://conductscience.org/library/papers/31867560PubMed
31572393The Rise of Coccidioides: Forces Against the Dust Devil Unleashed.Front Immunol2019https://conductscience.org/library/papers/31572393PubMed
23735673Penicillium species-induced granuloma in a cat resulting in chronic lower urinary tract disease.J Feline Med Surg2013https://conductscience.org/library/papers/23735673PubMed
22171289Investigation of microemulsion system for transdermal delivery of itraconazole.J Adv Pharm Technol Res2011https://conductscience.org/library/papers/22171289PubMed
18478363Dermatophytoses in animals.Mycopathologia2008https://conductscience.org/library/papers/18478363PubMed
14557297Current perspectives on ophthalmic mycoses.Clin Microbiol Rev2003https://conductscience.org/library/papers/14557297PubMed
10817701Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10817701PubMed
9527794Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9527794PubMed
8257124Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8257124PubMed
2847635Itraconazole pharmacokinetics in patients with renal dysfunction.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/2847635PubMed
2846299Treatment of systemic fungal infections: recent progress and current problems.Eur J Clin Microbiol Infect Dis1988https://conductscience.org/library/papers/2846299PubMed
2831809Azole antifungal agents: emphasis on new triazoles.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/2831809PubMed
2334152Induction potential of fluconazole toward drug-metabolizing enzymes in rats.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2334152PubMed
2203310In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2203310PubMed
2159257Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2159257PubMed
1925287Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review.Rev Infect Dis1991https://conductscience.org/library/papers/1925287PubMed
1648887High-dose itraconazole in the treatment of severe mycoses.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1648887PubMed
1418692Adverse drug reactions to systemic antifungals. Prevention and management.Drug Saf1992https://conductscience.org/library/papers/1418692PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3027845

GET https://conductscience.org/api/papers/v1/3027845/cited_by?page=2